Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
The Pharma Data
NOVEMBER 9, 2020
Furthermore, Amgen’s research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. 2005; 172; 149–60. 1,2 Expression of TSLP is increased in the airways of patients with asthma and has been correlated with disease severity. 7 Wenzel S.
52 
Let's personalize your content